Circulating Biomarker Signatures for the Detection of Gastric Preneoplasia and Cancer

The goal of this study is to characterize and validate a signature of circulating biomarkers in plasma, associated with the presence of gastric preneoplasia in patients with preexisting gastric lesion compared with a control group. For this purpose: * Patients with pre-existing gastric lesions will be invited to participate to this study. If they are willing to participate an additional blood sample (9 mL) will be collected at the time of the blood collection performed during their routine care * Healthy subjects will be invited to participate to constitute the control group. If they are wil

Trial Details

NCT ID
NCT05854368
Phase
NA
Sponsor
Institut Pasteur
Status
RECRUITING
Cancer Type
Gastric Cancer
Interventions
  • Additional blood collection as part of a blood sampling performed during routine care or specific for the research if not part of routine care.
  • Blood collection
Locations (sample)
  • Boulogne-Billancourt, France|48.83545,2.24128
  • Clichy, France|48.90018,2.30952
  • Le Kremlin-Bicêtre, France|48.81471,2.36073
  • Paris, France|48.85341,2.3488
  • Paris, France|48.85341,2.3488

Key Eligibility Criteria

  • 18 years old or highter
  • written informed consent prior to any study procedure
  • Affiliated to a social insurance system
  • Specific to patients with gastric lesions

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Gastric Cancer Trials on Trialify →